Neurology

Growing evidence suggests a link

Probably not, but pathogens that damage brains may earn a special place in cosmic hell

The evidence for neurostimulation is decidedly mixed

Science is taking a more personalized approach to treating the disorder and to understanding its diverse causes

A breakdown product of the drug reduces signs of depression in mice without side effects 

The disorder remains a medical mystery with no cure in sight, but some existing therapies produce lasting benefits, and more are on the horizon

Letters about Scientific American MIND’s Jan/Feb 2016 issue

Laura Glynn, a professor and chair of the department of psychology at Chapman University, explains

Ronald Crystal, chair of the Department of Genetic Medicine at Weill Cornell Medical College, replies

A new study adds to a heated debate about where pain signals are processed

Research on a key brain immune cell suggests it is a tantalizing but slippery target for new therapies